Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Navigating Technology Transfer
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Headline News
FDA approves Tecentriq combination as adjuvant treatment for stage III dMMR colon cancer
Vamikibart shows sustained one-year vision improvements in Phase III uveitic macular edema studies
Thermo Fisher expands drug development and manufacturing capabilities at CPHI Milan 2026
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Designing production facilities of the future
Presented by Geoffrey Hodge, Chief Technical Officer at Unum Therapeutics and Gary M. Pigeau, Ph.D., Director - Centre for Advanced Therapeutic Cell Technologies at GE Healthcare
30th July 2019
Characterization of Subvisible Particles in Protein and Viral Vaccines
Presented by Marina Kirkitadze,Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur and Bonnie Edwards, Product Manager of Imaging and MFI at ProteinSimple
21st May 2019
Points To Consider: Demonstrating Comparability Between Recombinant and Lysate Reagent For BET Testing
Presented by Karen Zink McCullough, Owner, Principal Consultant at MMI Associates, Nicola Reid, Associate Director Product Management, Endotoxin Products at Charles River Laboratories and Veronika Wills, Manager, Technical Services At Associates of Cape Cod, Inc
09th September 2021
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Lifetime study for JSR Amsphere A3 – protein A resin
Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















